Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.
about
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model VerificationUtility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound.Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effect.Experimental models for predicting drug absorption and metabolism.Selecting oral bioavailability enhancing formulations during drug discovery and development.Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.Mechanistic prediction of food effects for Compound A tablet using PBPK model.Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models.Use of preclinical dog studies and absorption modeling to facilitate late stage formulation bridging for a BCS II drug candidate.Application of Absorption Modeling in Rational Design of Drug Product Under Quality-by-Design Paradigm.Predictive Performance of Physiologically Based Pharmacokinetic Models for the Effect of Food on Oral Drug Absorption: Current Status.Pharmacokinetics, pharmacodynamics and food effect of LB30870, a novel direct thrombin inhibitor, after single oral doses in healthy men.
P2860
Q28088352-899329DD-586D-4EC7-A735-2628DE282DFBQ30662113-FDEFB87B-B694-43BB-8185-562A023660B2Q37671837-31D1F5CA-ACD3-4B2C-9918-FD0E4D2B68EBQ38107970-B5C24943-ADB6-4A53-8B1F-4A705D045322Q38175527-0F6AFCB7-E077-472D-802B-D9873B540E8AQ38351385-18C1D89A-7B97-4DFC-BAAB-5EFD52859B73Q38848902-ED67DBB7-9044-4A7A-AD12-0529C47A50C1Q38926514-9AABE70F-8DC3-41D7-BFC0-3F67BE10D01AQ40987176-53207A54-76BE-422E-84BD-8EDB77C97A4BQ41904429-4ECB11DA-7C6C-48B4-9917-FACB93457765Q41986678-B9BB9701-5250-41E5-A6CF-143172B60034Q49716638-ED372685-86D2-42C5-AD9A-04D234E91EB3Q51308018-FA5E78F9-C36A-4B40-BC78-1E560C1B3224
P2860
Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Case studies for practical foo ...... and preclinical in vivo data.
@ast
Case studies for practical foo ...... and preclinical in vivo data.
@en
type
label
Case studies for practical foo ...... and preclinical in vivo data.
@ast
Case studies for practical foo ...... and preclinical in vivo data.
@en
prefLabel
Case studies for practical foo ...... and preclinical in vivo data.
@ast
Case studies for practical foo ...... and preclinical in vivo data.
@en
P2093
P2860
P1433
P1476
Case studies for practical foo ...... and preclinical in vivo data.
@en
P2093
Binfeng Xia
Tsu-han Lin
Tycho Heimbach
P2860
P2888
P304
P356
10.1208/S12248-012-9419-5
P407
P577
2012-11-10T00:00:00Z
P5875
P6179
1035415049